Get sample copy: http://bit.ly/2EXE0jnnnThe major factors that drive the growth of the global ocular drug delivery technology market are the low bioavailability of drugs in conventional ocular therapies, increase in the incidence of glaucoma & macular degeneration, growing demand for targeted ocular drug delivery techniques, an increase in the number of approvals from government regulations for new ocular drug delivery techniques.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Ocular Drug Delivery Market by Technology (Topical, Iontophoresis, Ocular Insert [Erodible and Non-Erodible], Intraocular Implants [Biodegradable and Non-Biodegradable], In Situ Gel & Punctal Plugs, and Others), Formulation Type (Liposomes & Nanoparticles, Solution, Emulsion, Suspension, and Ointment), by Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and by End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, and Homecare Settings) - Global Opportunity Analysis and Industry Forecast, 2017-2023
The eye is a very valuable organ that can be affected by many diseases. These eye diseases can affect the body and the person may also lose their vision..
There are many drug delivery systems available in the market to treat these eye diseases..
As a result of efficient protective mechanisms of the eye, there are a few ophthalmic drugs available in the market. Almost 70% of the eye dosage formulations available in the market are in the form of eye drops and ointments.
The low bioavailability of drugs in conventional ocular therapies are enhancing the growth of ocular drug delivery market.
Favorable reimbursement policies and rise in funding to develop advanced drug delivery systems can help boost the market growth.
Other factorsthat contribute to market growth are:
Increase in the incidence of glaucoma & macular degeneration.
Growing demand for targeted ocular drug delivery techniques.
Increase in the number of approvals from government regulations for new ocular drug delivery techniques.
The leading players in the Ocular Drug Delivery Market have adopted key strategies such as collaborations, agreement and acquisition to expand their market presence.
Valeant Pharmaceuticals International, Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Graybug Vision Inc., EyeGate Pharma, Clearside Biomedical, Inc., Alimera Sciences, EyeGate Pharma, Envisia Therapeutics, and Allergan, Plc. are the key players in this industry.
A report titled “Ocular Drug Delivery Market - Opportunities and Forecasts, 2017 – 2023” has been recently published by Allied Market Research. It makes an in-depth analysis of current trends, drivers, and restraining factors that affect financial ratios relevant to the industry. Company profiles for key vendors in business builds a comprehensive picture of profitable opportunities from stakeholder’s perspective.
To know more about the Ocular Drug Delivery Market - Opportunities and Forecasts, 2017 – 2023 report:
Follow us on